Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study

INTRODUCTION: We aimed to investigate the efficacy and side effects of bendamustine in relapsed/refractory lymphoma patients in Turkey. MATERIAL AND METHODS: In this retrospective study, we included relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) patients who underwent multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Karadurmus, Nuri, Paydas, Semra, Esin, Ece, Surmeli, Zeki Gokhan, Yildiz, Birol, Erturk, Ismail, Nayir, Erdinc, Dogan, Mutlu, Sumbul, Ahmet Taner, Barista, Ibrahim, Gurkan, Emel, Ocal, Ramazan, Ferhanoglu, Burhan, Ozgur, Gokhan, Karakas, Yusuf, Lacin, Sahin, Ozaydin, Sukru, Petekkaya, Halil Ibrahim, Uskent, Necdet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314394/
https://www.ncbi.nlm.nih.gov/pubmed/34336021
http://dx.doi.org/10.5114/aoms.2019.83000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314394/
https://www.ncbi.nlm.nih.gov/pubmed/34336021
http://dx.doi.org/10.5114/aoms.2019.83000

Ejemplares similares